Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BY 4.0Frontiers in Molecular Biosciences

Identification and characterization of a novel fungal pyranose 2-oxidase from the Punctularia strigosozonata with potent cytotoxicity against pancreatic carcinoma cell lines

Abstract

Pyranose oxidase (POx) is a FAD-dependent oxidoreductase that catalyzes the oxidation of D-glucose to 2-keto-D-glucose with concomitant production of hydrogen peroxide (H2O2). Although POx has been well characterized in several fungi and bacteria, its potential in cancer therapy remains largely unexplored. In this study, we identified a novel pyranose 2-oxidase, designated PsPOx, from the wood-decaying fungus Punctularia strigosozonata through gene mining. The gene was codon-optimized, synthesized, and heterologously expressed in Escherichia coli. The recombinant enzyme was purified and biochemically characterized. Sequence alignment and structural modeling confirmed that PsPOx possesses all conserved features of the GMC superfamily. Kinetic analysis showed that PsPOx exhibits the highest catalytic efficiency (kcat/Km = 85.09 mM-1 s-1) towards D-glucose, with a Km value of 0.8375 mM, indicating a strong substrate affinity. Using the CCK-8 assay, PsPOx demonstrated potent dose-dependent cytotoxicity against three human pancreatic carcinoma cell lines (PANC-1, AsPC-1, and BxPC-3), with IC50 values of 257.8, 195.2, and 176.2 ng mL-1, respectively. However, the IC50 value for the normal human pancreatic epithelial cell line hTERT-HPNE was 195.6 ng mL-1, which was comparable to those for AsPC-1 and BxPC-3, indicating that free PsPOx lacks selectivity between tumor and normal cells. Mechanistic studies revealed that PsPOx treatment increased intracellular and mitochondrial reactive oxygen species (ROS) levels, induced G0/G1 cell cycle arrest, downregulated Cyclin D1 and PCNA expression, and triggered apoptosis in BxPC-3 cells. These results preliminarily demonstrate that PsPOx possesses antitumor activity in vitro and may serve as a candidate for further development.

Related

  1. Ni(II) Complexes of 2-Imine-8-Hydroxyquinolines: Characterization, Albumin Binding and Cytotoxicity
    Sofia Marcão, Leonor Côrte-Real, Alice Alborghetti +7
    InorganicsPeer-reviewedCC BY 4.0Full textGeneral biologyInorganic & organometallic chemistryHAL
  2. Lipid Extract from Ulva ohnoi Algae: Chemical Characterization, Antibacterial Potential, and Cytotoxicity in the Search for New Agents Against MDR Infections.
    Marisa Castro Jara, Diego Serrasol do Amaral, Leonardo Werner +12
    Marine biotechnology (New York, N.Y.)Peer-reviewedCC BYFull textEcologyEurope PMC
  3. Identification and characterization of two transmembrane proteins required for virulence of Ustilago maydis
    Paul Weiland, Florian Altegoer
    Frontiers in Plant SciencesPreprintLicence not statedStructural biologyGeneral biologyHAL
  4. Comprehensive identification, characterization, and stress response analysis of the ZmSPL gene family in maize (Zea mays L.)
    Lei Gu, Chunyu Zhang, Ruoyue Chen +2
    BMC GenomicsPeer-reviewedCC BY 4.0Genetics & genomicsCrossref
  5. Identification and characterization of inflammatory LILR and fibrotic SPP1 macrophages in chronic lung allograft dysfunction
    A. Duong, S. Moshkelgosha, A. Wong +9
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
BibTeX
@article{guo2026identification,
  title = {{Identification and characterization of a novel fungal pyranose 2-oxidase from the Punctularia strigosozonata with potent cytotoxicity against pancreatic carcinoma cell lines}},
  author = {Jiyang Guo and Junling Liu and Long Xu and Tingyi Yan and Zhendong Zheng},
  journal = {Frontiers in Molecular Biosciences},
  year = {2026},
  month = oct,
  doi = {10.3389/fmolb.2026.1914323},
  url = {https://www.frontiersin.org/articles/10.3389/fmolb.2026.1914323},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Identification and characterization of a novel fungal pyranose 2-oxidase from the Punctularia strigosozonata with potent cytotoxicity against pancreatic carcinoma cell lines
AU  - Jiyang Guo
AU  - Junling Liu
AU  - Long Xu
AU  - Tingyi Yan
AU  - Zhendong Zheng
PY  - 2026
DA  - 2026/10/28
JO  - Frontiers in Molecular Biosciences
DO  - 10.3389/fmolb.2026.1914323
UR  - https://www.frontiersin.org/articles/10.3389/fmolb.2026.1914323
AB  - Pyranose oxidase (POx) is a FAD-dependent oxidoreductase that catalyzes the oxidation of D-glucose to 2-keto-D-glucose with concomitant production of hydrogen peroxide (H2O2). Although POx has been well characterized in several fungi and bacteria, its potential in cancer therapy remains largely unexplored. In this study, we identified a novel pyranose 2-oxidase, designated PsPOx, from the wood-decaying fungus Punctularia strigosozonata through gene mining. The gene was codon-optimized, synthesized, and heterologously expressed in Escherichia coli. The recombinant enzyme was purified and biochemically characterized. Sequence alignment and structural modeling confirmed that PsPOx possesses all conserved features of the GMC superfamily. Kinetic analysis showed that PsPOx exhibits the highest catalytic efficiency (kcat/Km = 85.09 mM-1 s-1) towards D-glucose, with a Km value of 0.8375 mM, indicating a strong substrate affinity. Using the CCK-8 assay, PsPOx demonstrated potent dose-dependent cytotoxicity against three human pancreatic carcinoma cell lines (PANC-1, AsPC-1, and BxPC-3), with IC50 values of 257.8, 195.2, and 176.2 ng mL-1, respectively. However, the IC50 value for the normal human pancreatic epithelial cell line hTERT-HPNE was 195.6 ng mL-1, which was comparable to those for AsPC-1 and BxPC-3, indicating that free PsPOx lacks selectivity between tumor and normal cells. Mechanistic studies revealed that PsPOx treatment increased intracellular and mitochondrial reactive oxygen species (ROS) levels, induced G0/G1 cell cycle arrest, downregulated Cyclin D1 and PCNA expression, and triggered apoptosis in BxPC-3 cells. These results preliminarily demonstrate that PsPOx possesses antitumor activity in vitro and may serve as a candidate for further development.
SN  - 2296-889X
ER  -